The TRIPS Agreement recognizes abuses inherent in the IP monopoly along with the fact that competition policy plays a significant role in dealing with such abuses. The relationship of competition policy with intellectual property rights has three important dimensions: (a) where the abuse...

In 2002, a number of associations requested the Korean Patent Office to issue a compulsory license for the manufacture of Gleevec, a drug under Novartis' patent under the Korean patent provision which permits issue of compulsory licensing for public non-commercial use. This provision in the...